Login / Signup

Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice.

Jingyi XuLiyue ZhuHongyang LiuMengye LiYingshu LiuFan YangZuo-Wei Pei
Published in: Lipids in health and disease (2018)
These results indicate that thymoquinone may provide a potential therapeutic target for cardiac damage caused by hypercholesterolemia.
Keyphrases
  • left ventricular
  • oxidative stress
  • cardiovascular events
  • heart failure
  • cardiovascular disease
  • risk assessment
  • atrial fibrillation
  • climate change